Drug Type Recombinant polypeptide, Biosimilar |
Synonyms Livogiva |
Target |
Action agonists, stimulants |
Mechanism PTH1R agonists(Parathyroid hormone receptor agonists), Osteogenesis stimulants, Parathyroid hormone replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date European Union (27 Aug 2020), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Osteoporosis | Norway | 27 Aug 2020 | |
Osteoporosis | Iceland | 27 Aug 2020 | |
Osteoporosis | European Union | 27 Aug 2020 | |
Osteoporosis | Liechtenstein | 27 Aug 2020 |